1-3 of 3
Elena Barisone, MD
Close
Sort by
Journal Articles

Clonal Evolution and Lack of BCR-ABL1 Mutations in Pediatric Ph+ ALL Patients Resistant/Refractory to Imatinib Treatment

Valeria Cazzaniga, PhD, Paola De Lorenzo, Federica Mottadelli, Grazia Fazio, PhD, Tiziana Villa, Vincenzo Rossi, Martina Pigazzi, PhD, Marcela B. Mansur, PhD, Marco Zecca, MD, Elena Barisone, MD, Franco Locatelli, MD, Giuseppe Basso, Prof, MD, Maria Grazia Valsecchi, PhD, Mel Greaves, FRS, Andrea Biondi, Prof, MD, Anthony M Ford, Giovanni Cazzaniga
Journal: Blood
Blood (2015) 126 (23): 2622.
https://doi.org/10.1182/blood.V126.23.2622.2622
Published: 2015
Journal Articles

Relapse in Childhood “Very High Risk” Acute Lymphoblastic Leukemia Treated with BFM Chemotherapy Has a Dismal Outcome Even When Treated with Transplantation.

Adriana Balduzzi, MD, Maria Grazia Valsecchi, PhD, André Schrauder, MD, Daniela Silvestri, MSc, Barbara Buldini, MD, Arend von Stackelberg, MD, Anna Maria Testi, MD, Thomas Klingebiel, MD, Christina Peters, MD, Carmelo Rizzari, MD, Elena Barisone, MD, Martin Schrappe, MD
Journal: Blood
Blood (2008) 112 (11): 915.
https://doi.org/10.1182/blood.V112.11.915.915
Published: 2008
Journal Articles

Prognostic Impact of Minimal Residual Disease (MRD) in Children Is Different in B or T Lineage Acute Lymphoblastic Leukemia: Results of Trial AIEOP-BFM ALL 2000.

Martin Schrappe, MD, Carmelo Rizzari, MD, Georg Mann, MD, Anja Möricke, MD, Maria Grazia Valsecchi, PhD, Martin Zimmermann, PhD, Claus R. Bartram, MD, Renate Panzer-Grümayer, MD, André Schrauder, MD, Gianni Cazzaniga, PhD, Thomas Flohr, PhD, Rosanna Parasole, MD, Alfred Reiter, MD, Wolf-Dieter Ludwig, MD, Luca Lo Nigro, MD, Giuseppe Basso, MD, Giulio De Rossi, MD, Elena Barisone, MD, Felix Niggli, MD, Helmut Gadner, MD, Valentino Conter, MD
Journal: Blood
Blood (2007) 110 (11): 1425.
https://doi.org/10.1182/blood.V110.11.1425.1425
Published: 2007